Objectives To investigate short-term prognosis and prognostic factors for connective tissue disease-associated pneumocystis pneumonia (CTD-PCP ... and the 30-day and 60-day in-hospital survival rates ...

Those with fungal infections and weakened immune systems may develop pneumonia due to fungi like Pneumocystis jirovecii ... expert will decide the line of treatment. To treat this condition ...

HIV increases the risk of other infectious respiratory diseases, including Pneumocystis jirovecii pneumonia and ... and effective treatment strategies for both HIV and TB, including rapid ...

Pneumonia is a lung infection that can be caused by a number of different organisms, including bacteria, viruses, and fungi. It happens when your immune system isn't able to prevent these organisms ...

Treatment depends on how deep the melanoma is and whether it has spread. This is called the stage of the cancer. Treatment also depends on your general health and where the melanoma is on your body.

Efficacy was maintained or improved up to week 52. Abatacept was well tolerated with no new safety signals. Conclusions Abatacept treatment of PsA in this phase III study achieved its primary end ...

The “silent treatment” is when a person refuses to communicate with someone because they are angry or upset. It can sometimes be a form of emotional abuse. The silent treatment may be abusive ...

Immunosuppressive treatment was arranged in accordance with the protocols of our transplant team. Three months of trimethoprim-sulfamethoxazole (TMP-SMX) 480 mg daily against Pneumocystis jirovecii ...

It is classified as cutaneous T-cell lymphoma by the World Health Organization (WHO) and the European Organization for Research and Treatment of Cancer (EORTC), which proposed ... at risk of ...